← Back to Ultralife Corp
Stoqly stoqly.net Company report Β· October 27, 2026

Ultralife Corp

ULBI NasdaqΒ· Miscellaneous Electrical Machinery, Equipment & Supplies

Last close Β· Oct 23, 2026

$6.07

KIRA Β· Stoqly’s AI analyst, in plain words

  • Ultralife Corp had $191M of revenue in fiscal 2025, up 16.2% on the year before. Over five years, revenue changed +12.2% a year on average.
  • Its operating margin was βˆ’3.1%, down 9.1Β pts: of every 100 in sales, about βˆ’3 is left after running the business.
  • Ultralife Corp lost $5.9M in fiscal 2025.
  • Free cash flow was $7.1M in fiscal 2025, 3.7% of revenue.
  • Ultralife Corp owes $40.3M more than it holds in cash.

Market cap

$101M

P/E

β€”

Revenue

$191M

Net income

βˆ’$5.9M

Free cash flow

$7.1M

Operating margin

βˆ’3.1%

Ultralife Corp in 30 seconds Β· fiscal 2025

Good

Are sales growing?

+16.2%

Yes. Sales grew 16.2% last year.

Weak

Does it make a profit?

βˆ’3.1%

No. It lost money last year.

So-so

Does profit turn into cash?

3.7%

Partly. 3.7% of sales ends up as free cash.

So-so

How healthy are the accounts?

5 / 9

Mixed. It passes 5 of 9 health tests.

For information

How is the share priced?

β€”

No P/E: it made no profit over the last four quarters.

What Ultralife Corp does

No business description yet.

Fiscal year ends
December 31, 2025
Latest annual report
10-K Β· Mar 23, 2026
Legal name
ULTRALIFE CORP
CIK
0000875657
stoqly.net Β· ULBI Β· Generated October 27, 2026 Not investment advice Β· Page 1 of 3
Stoqly stoqly.net Company report Β· October 27, 2026

Ultralife Corp Β· ULBI

Results and finances

The last 5 fiscal years. Amounts in USD.

Fiscal yearFY21FY22FY23FY24FY25
Sales and profit
Revenue $98.3M $132M $159M $164M $191M
Revenue growth βˆ’8.8% 34.2% 20.3% 3.7% 16.2%
Gross margin 25.1% 22.3% 24.7% 25.7% 24.1%
Operating margin 0.0% 0.1% 6.0% 6.1% βˆ’3.1%
Net income βˆ’$0.2M βˆ’$0.1M $7.2M $6.3M βˆ’$5.9M
Net margin βˆ’0.2% βˆ’0.1% 4.5% 3.8% βˆ’3.1%
Diluted EPS $0.05 $0.05 $0.44 $38.00 βˆ’$35.00
Cash
Cash from operations $4.3M βˆ’$1.3M $1.9M $16.6M $11.0M
Capital expenditure $2.8M $1.7M $2.6M $1.9M $3.9M
Free cash flow $1.5M βˆ’$2.9M βˆ’$0.6M $14.7M $7.1M
FCF margin 1.5% βˆ’2.2% βˆ’0.4% 8.9% 3.7%
Share count change 99,508.7% 0.5% 0.6% 3.3% βˆ’0.7%
Debt and strength
Cash and short-term investments $8.3M $5.6M $10.2M $6.9M $9.3M
Debt incl. finance leases $20.9M $21.5M $25.7M $55.0M $49.7M
Shareholders' equity $118M $116M $125M $134M $130M
Net debt / EBITDA 3.5x 3.5x 1.2x 3.7x β€”
Current ratio 3.5x 2.7x 3.8x 3.3x 2.8x
Returns and quality
Return on capital 0.0% 0.1% 5.3% 4.2% βˆ’2.7%
Return on equity βˆ’0.2% βˆ’0.1% 6.0% 4.9% βˆ’4.5%
Return on tangible equity βˆ’0.4% βˆ’0.2% 9.9% 9.8% βˆ’8.0%
Piotroski F-score 3 3 6 4 5
Altman Z'' 3.9 3.4 4.5 3.4 2.9

Insiders bought, 12 months

$2.5M

4 insiders

Insiders sold, 12 months

$0.0M

0 insiders

Of sales under plans

β€”

$0.0M

How to read these numbers

Revenue:
Total sales reported in the income statement.
Operating margin:
Operating income as a share of revenue.
Net income:
Profit after all expenses, interest and tax.
Free cash flow:
Cash from operations minus capital spending.
Net debt / EBITDA:
Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
Return on capital:
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
stoqly.net Β· ULBI Β· Generated October 27, 2026 Not investment advice Β· Page 2 of 3
Stoqly stoqly.net Company report Β· October 27, 2026

Ultralife Corp Β· ULBI

Charts and comparison

Ten years at a glance, and how it stacks up against similar companies.

Revenue

Net income

Margins, % of revenue

Gross Operating Net

Cash vs debt (incl. leases)

Cash Debt

Free cash flow

Dividends and buybacks

Dividends Buybacks

KIRA

At $6.07 a share, the company is worth $101M.

Source: SEC EDGAR XBRL filings (CIK 0000875657). Data updated October 24, 2026. For information only β€” not investment advice. Check the original filings before relying on any figure.